Skip to main content
رجوع
Watch Compare

Hoth Therapeutics, Inc.

جودة البيانات: 83%
HOTH
Nasdaq Manufacturing Chemicals
KWD 0.54
▼ KWD 0.02 (-4.04%)
القيمة السوقية: 10.32 M
السعر
KWD 0.54
القيمة السوقية
10.32 M
نطاق اليوم
KWD 0.53 — KWD 0.57
نطاق 52 أسبوعًا
KWD 0.50 — KWD 2.12
حجم التداول
272,314
فتح KWD 0.56
متوسط 50 يوم / 200 يوم
KWD 0.94
42.35% below
متوسط 50 يوم / 200 يوم
KWD 1.22
55.64% below

Quick Summary

النقاط الرئيسية

Negative free cash flow of -9.80 M

النمو

Revenue Growth (5Y)
N/A
Revenue (1Y)N/A
Earnings (1Y)N/A
FCF Growth (3Y)N/A

الجودة

Return on Equity
-138.74%
أقل من متوسط القطاع (-53.41%)
ROIC-108.66%
Net MarginN/A
Op. MarginN/A

الأمان

Debt / Equity
N/A
Current Ratio8.81
Interest CoverageN/A

التقييم

PE (TTM)
-0.83
أعلى من متوسط القطاع (-1.48)
P/B Ratio1.25
EV/EBITDAN/A
Dividend YieldN/A

تاريخ السعر

الاتجاهات المالية

مقارنة الأقران

مقابل وسيط قطاع Manufacturing (1364 نظير)
المقياس السهم وسيط القطاع
P/E -0.8 -1.5
P/B 1.3 1.6
ROE % -138.7 -53.4
Net Margin % — -41.5
Rev Growth 5Y % — 1.8
D/E — 0.3

All Fundamental Metrics
Growth
Revenue Growth (1Y) N/A Revenue Growth (3Y) N/A
Earnings Growth (1Y) N/A Earnings Growth (3Y) N/A
Revenue Growth (5Y) N/A Earnings Growth (5Y) N/A
Profitability
Revenue (TTM) N/A Net Income (TTM) -12.47 M
ROE -138.74% ROA -128.87%
Gross Margin N/A Operating Margin N/A
Net Margin N/A Free Cash Flow (TTM) -9.80 M
ROIC -108.66% FCF Growth (3Y) N/A
Safety
Debt / Equity N/A Current Ratio 8.81
Interest Coverage N/A Asset Turnover N/A
Working Capital 7.91 M Tangible Book Value 8.23 M
Dividends
Dividend Yield N/A Payout Ratio N/A
Dividend Growth (3Y) N/A Dividend Growth (5Y) N/A
Consecutive Div Years N/A
Valuation
P/E Ratio -0.83 Forward P/E N/A
P/B Ratio 1.25 P/S Ratio N/A
PEG Ratio N/A Forward PEG N/A
EV/EBITDA N/A Fwd EV/EBITDA N/A
Forward P/S N/A Fwd Earnings Yield N/A
FCF Yield -94.99%
Market Cap 10.32 M Enterprise Value 2.47 M
Per Share
EPS (Diluted TTM) -0.90 Revenue / Share N/A
FCF / Share -0.51 OCF / Share -0.51
EPS CAGR (1Y) N/A EPS CAGR (5Y) N/A
EPS CAGR (10Y) N/A
Efficiency
CapEx / Revenue N/A FCF Conversion 78.62%
SBC-Adj. FCF -11.28 M Growth Momentum N/A

Income Statement

Annual, most recent first
Metric FY2025 FY2024 FY2023 FY2022 FY2021
Revenue — — — — —
Net Income -12.47 M -8.19 M -7.85 M -11.37 M -14.31 M
EPS (Diluted) -0.90 -1.28 -2.30 -8.79 —
Gross Profit — — — — —
Operating Income -12.36 M -8.22 M -7.69 M -11.07 M -14.10 M
EBITDA — — — — —
R&D Expenses 5.95 M 3.25 M 3.48 M 4.84 M 7.35 M
SG&A Expenses — — — — —
D&A — — — — —
Interest Expense — — — — —
Income Tax — — — — —

Balance Sheet

Annual, most recent first
Metric FY2025 FY2024 FY2023 FY2022 FY2021
Total Assets 7.60 M 7.71 M 9.52 M 6.76 M 10.99 M
Total Liabilities 1.45 M 833,906.0 704,983.0 1.64 M 1.10 M
Shareholders' Equity 6.15 M 6.88 M 8.82 M 5.12 M 9.88 M
Total Debt — — — — —
Cash & Equivalents 6.25 M 7.04 M 9.29 M 6.43 M 8.54 M
Current Assets 6.86 M 7.64 M 9.43 M 6.73 M 10.58 M
Current Liabilities 1.45 M 831,197.0 678,657.0 1.39 M 867,787.0